Pfizer Inc. (PFE) Q2 2016 Earnings Results

Pfizer Beats on EPS, Stock Down 2.47%

Pfizer's earnings report showed a slight beat on EPS, which indicates some positive performance despite broader challenges. However, the stock fell by 2.47%, likely reflecting investor concerns about the lack of revenue data and the overall market environment. The cautious tone from management suggests that investors should remain vigilant about future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.64	N/A	+2.56%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Defensive

Overall, management conveyed a cautious outlook amid market uncertainties. They stressed the need for continued focus on innovation.

Management highlighted ongoing challenges in the market.

They emphasized the importance of strategic investments moving forward.

Pfizer Beats on EPS, Stock Down 2.47%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Beats on EPS, Stock Down 2.47%

Key numbers

Management commentary